AstraZeneca Puts UK Investment Plans on Hold Amid Challenging Business Environment
Published on: Sept. 12, 2025, 10:22 p.m. | Source: Devdiscourse
AstraZeneca has paused a planned £200 million expansion at its Cambridge site, citing a challenging UK business environment. This follows the company's earlier decision to scrap a £450 million investment in a vaccine plant. The suspension reflects broader industry concerns over the UK's pharmaceutical policies.
